» Articles » PMID: 37873636

CRISPR-Cas Technology As a Revolutionary Genome Editing Tool: Mechanisms and Biomedical Applications

Overview
Journal Iran Biomed J
Date 2023 Oct 24
PMID 37873636
Authors
Affiliations
Soon will be listed here.
Abstract

Programmable nucleases are powerful genomic tools for precise genome editing. These tools precisely recognize, remove, or change DNA at a defined site, thereby, stimulating cellular DNA repair pathways that can cause mutations or accurate replacement or deletion/insertion of a sequence. CRISPR-Cas9 system is the most potent and useful genome editing technique adapted from the defense immune system of certain bacteria and archaea against viruses and phages. In the past decade, this technology made notable progress, and at present, it has largely been used in genome manipulation to make precise gene editing in plants, animals, and human cells. In this review, we aim to explain the basic principle, mechanisms of action, and applications of this system in different areas of medicine, with emphasizing on the detection and treatment of parasitic diseases.

Citing Articles

Impact of Heavy Metal Pollution in the Environment on the Metabolic Profile of Medicinal Plants and Their Therapeutic Potential.

Asiminicesei D, Fertu D, Gavrilescu M Plants (Basel). 2024; 13(6).

PMID: 38592933 PMC: 10976221. DOI: 10.3390/plants13060913.


Co-delivery of Cas9 mRNA and guide RNAs for editing of LGMN gene represses breast cancer cell metastasis.

Wang Y, Peng Y, Zi G, Chen J, Peng B Sci Rep. 2024; 14(1):8095.

PMID: 38582932 PMC: 10998893. DOI: 10.1038/s41598-024-58765-6.

References
1.
Huang X, Wang Y, Yan W, Smith C, Ye Z, Wang J . Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation. Stem Cells. 2015; 33(5):1470-9. PMC: 4628786. DOI: 10.1002/stem.1969. View

2.
Hille F, Charpentier E . CRISPR-Cas: biology, mechanisms and relevance. Philos Trans R Soc Lond B Biol Sci. 2016; 371(1707). PMC: 5052741. DOI: 10.1098/rstb.2015.0496. View

3.
Sanchez-Rivera F, Papagiannakopoulos T, Romero R, Tammela T, Bauer M, Bhutkar A . Rapid modelling of cooperating genetic events in cancer through somatic genome editing. Nature. 2014; 516(7531):428-31. PMC: 4292871. DOI: 10.1038/nature13906. View

4.
Boch J, Scholze H, Schornack S, Landgraf A, Hahn S, Kay S . Breaking the code of DNA binding specificity of TAL-type III effectors. Science. 2009; 326(5959):1509-12. DOI: 10.1126/science.1178811. View

5.
Feng W, Zong W, Wang F, Ju S . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review. Mol Cancer. 2020; 19(1):100. PMC: 7264920. DOI: 10.1186/s12943-020-01218-1. View